Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Cubase Bio AB
AB
Active
Org 5594835620
Nobels Väg 16, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 2 years old
6 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cubase Bio AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
SEK millions
0M
-3M
-6M
-8M
-11M
-3M
2024
-9M
-200%
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
0
0
Staff expenses
−1 266
−4 842
EBITDA
−3 245
−8 675
Depreciation & amort.
—
−13
EBIT
−3 245
−8 688
Net financials
0
124
Profit before tax
−3 245
−8 564
Tax
—
—
Net profit
−3 245
−8 564
Balance sheet
SEK thousands
Item
2024
2025
Total assets
13 517
5 605
Equity
13 101
4 537
Long-term debt
—
—
Short-term debt
415
1 068
Total debt
415
1 068
Financial ratios
5-year trend
EBITDA-margin
-867463500.0%
This company
15.8%
Market median
-5490275416% vs market
2024
2025
Soliditetsgrad
80.9%
This company
38.2%
Market median
+112% vs market
2024
2025
Egenkapitalforrentning
-188.8%
This company
18.4%
Market median
-1126% vs market
2024
2025
Nettoresultatgrad
-856412000.0%
This company
8.1%
Market median
-10572987754% vs market
2024
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2024
2025
Gæld/egenkapital
0.24×
This company
0.62×
Market median
+61% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-05-16 – 2024-12-31
View
PDF
More on Cubase Bio AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network